RxSight (RXST) director Shweta Maniar receives 37,037 RSU award

Rhea-AI Filing Summary

Maniar Shweta reported acquisition or exercise transactions in this Form 4 filing.

RxSight, Inc. director Shweta Maniar received a grant of 37,037 restricted stock units (RSUs) of Common Stock. The award was reported at a price of $0.00 per share, consistent with a compensation grant rather than a market purchase.

Each RSU represents the right to receive one share of RxSight Common Stock. The RSUs will vest in full if Maniar continues as an Outside Director until the earlier of the one-year anniversary of the June 17, 2026 grant date or the next annual meeting of stockholders following that date. After this award, Maniar directly holds 55,172 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Maniar Shweta

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	37,037	$0.00	--

Holdings After Transaction: Common Stock — 55,172 shares (Direct, null)

Footnotes (1)

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.

Key Figures

RSUs granted: 37,037 RSUs Grant price per share: $0.00 per share Shares after transaction: 55,172 shares +1 more

4 metrics

RSUs granted 37,037 RSUs Grant of restricted stock units on June 17, 2026

Grant price per share $0.00 per share Reported price for RSU award

Shares after transaction 55,172 shares Total direct holdings following RSU grant

Vesting schedule 100% cliff vest Earlier of 1-year from June 17, 2026 or next annual meeting

Key Terms

restricted stock unit ("RSU"), Outside Director, 2021 Equity Incentive Plan, annual meeting of stockholders

4 terms

restricted stock unit ("RSU") financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Outside Director financial

"Subject to the Reporting Person's continuing as an Outside Director through such applicable vesting date"

2021 Equity Incentive Plan financial

"Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan)"

annual meeting of stockholders financial

"the date of the next annual meeting of stockholders following the Date of Grant"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maniar Shweta

(Last) (First) (Middle)

C/O RXSIGHT, INC.

100 COLUMBIA

(Street)

ALISO VIEJO CALIFORNIA 92656

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/17/2026		A		37,037(2)	A	(1)	55,172	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.

2. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Jim Schindler, as Attorney-in-Fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did RxSight (RXST) director Shweta Maniar report in this Form 4?

Shweta Maniar reported receiving a grant of 37,037 restricted stock units (RSUs) of RxSight Common Stock. This is a compensation-related award at $0.00 per share, not an open-market stock purchase or sale.

How many RxSight (RXST) shares does Shweta Maniar hold after this RSU grant?

Following the RSU grant, Shweta Maniar directly holds 55,172 shares of RxSight Common Stock. This figure includes the newly awarded RSUs as reported in the Form 4 for this grant transaction.

When do Shweta Maniar’s new RxSight (RXST) RSUs vest?

The RSUs vest 100% on the earlier of the one-year anniversary of the June 17, 2026 grant date or the date of the next annual meeting of stockholders, assuming she continues to serve as an Outside Director through that vesting date.

What does each RSU granted to Shweta Maniar by RxSight (RXST) represent?

Each restricted stock unit (RSU) represents a contingent right to receive one share of RxSight, Inc. Common Stock. Shares are actually delivered only after the RSUs vest under the terms of the company’s equity plan.

Is Shweta Maniar’s RxSight (RXST) Form 4 transaction a stock purchase or sale?

No. The Form 4 reflects a grant or award acquisition of RSUs at $0.00 per share. It is part of director compensation, not an open-market stock purchase or sale transaction.

Under which plan were the RxSight (RXST) RSUs granted to Shweta Maniar?

The RSUs were granted under RxSight’s 2021 Equity Incentive Plan. Vesting requires that Shweta Maniar continue serving as an Outside Director through the applicable vesting date described in the award terms.